首页> 外文期刊>Molecular cancer research: MCR >Genomic and epigenomic cross-talks in the regulatory landscape of miRNAs in breast cancer
【24h】

Genomic and epigenomic cross-talks in the regulatory landscape of miRNAs in breast cancer

机译:乳腺癌中miRNA调控格局中的基因组和表观基因组串扰

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNA) are a class of endogenous, small noncoding RNAs found in animals, plants, and viruses that control their target gene expression posttranscriptionally. They are involved in a wide array of biological processes including cell differentiation, development, cell death and homeostasis, and fine-tune the regulation of these pathways. Their aberrant expressions have been associated with different diseases. These small RNAs are also known to function as oncogenes, oncosupressor genes, modulators of metastatic spread, and regulators of cancer stem cells. Their deregulation is a hallmark of different cancers types including breast cancer. Despite the growing evidence for their involvement in breast cancer, understanding the interplay between miRNAs and their targets leading to the disease remains largely unknown. Here, we provide a comprehensive story on miRNA signatures of breast cancer, miRNAs in breast cancer stem cells, metastamirs (i.e., metastasis regulatory miRNAs), circulating miRNAs as invasive blood-based biomarkers, and oncomiRs and oncosupressor miRNAs associated with breast cancer. Furthermore, we provide biological insights on their regulation by various mechanisms including genomic alterations and demonstration of a complicated feedback network between miRNAs and epigenetic regulators forming an epigenetics-miRNA regulatory circuit whose disruption may underlie the cause of breast cancer.
机译:微小RNA(miRNA)是在动物,植物和病毒中发现的一类内源性小非编码RNA,它们可转录后控制其靶基因的表达。他们参与了许多生物学过程,包括细胞分化,发育,细胞死亡和体内平衡,并对这些途径的调控进行了微调。它们的异常表达与不同的疾病有关。还已知这些小RNA充当癌基因,癌抑制基因,转移扩散的调节剂和癌症干细胞的调节剂。他们的放松管制是包括乳腺癌在内的各种癌症类型的标志。尽管越来越多的证据表明它们参与了乳腺癌,但对miRNA与导致该疾病的靶标之间的相互作用的了解仍然未知。在这里,我们提供了关于乳腺癌的miRNA特征,乳腺癌干细胞中的miRNA,metastamirs(即转移调节性miRNA),作为侵入性血液生物标记的循环miRNA以及与乳腺癌相关的oncomiR和癌抑制素miRNA的综合报道。此外,我们通过各种机制对它们的调控提供生物学见解,包括基因组改变以及在miRNA和表观遗传调节剂之间形成复杂的反馈网络的证明,这些反馈网络形成表观遗传学-miRNA调节回路,其破坏可能是乳腺癌的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号